dc.contributor.author |
Gallwitz, Baptist |
|
dc.date.accessioned |
2021-10-28T07:34:23Z |
|
dc.date.available |
2021-10-28T07:34:23Z |
|
dc.date.issued |
2021 |
|
dc.identifier.issn |
1664-2392 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/120167 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Frontiers Media Sa |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.3389/fendo.2021.645507 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20210824232002_00574 |
|
utue.personen.roh |
Gallwitz, Baptist |
|
utue.personen.roh |
Giorgino, Francesco |
|
dcterms.isPartOf.ZSTitelID |
Frontiers in Endocrinology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 645507 |
de_DE |
dcterms.isPartOf.ZS-Volume |
12 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |